Condition: Abdominal Aortic Aneurysm · Sponsor: Erasmus Medical Center
The BIOMArCS-AAA study aims to investigate the associations of (temporal patterns of) blood biomarkers with aneurysm growth in patients with abdominal aortic aneurysm (AAA), with particular attention to biomarkers that have demonstrated prognostic value for adverse disease outcomes in coronary artery disease and biomarkers for the main genetic pathways associated with AAA.
This description comes directly from the study's public registry record.
Isabella Kardys, MD, PhD · +31650032051 · i.kardys@erasmusmc.nl
Eric Boersma, MSc, PhD · +31107031814 · h.boersma@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Erasmus Medical Center | Rotterdam, South Holland, Netherlands | Recruiting |
| Maasstad Ziekenhuis | Rotterdam, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03703947